Ludwigite is the main available boron-bearing resource in China. In order to enrich the theory system and optimize its utilization processes, this paper study the mechanism and kinetics on non-isothermal decomposition of ludwigite in inert atmosphere by means of thermal analysis. Results show that, the decomposition of serpentine and szajbelyite is the main cause of mass loss in the process. At the end of decomposition, hortonolite and ludwigite are the two main phases in the sample. The average E value of structural water decomposition is 277.97 kJ/mol based on FWO method (277.17 kJ/mol based on KAS method). The results is proved to be accurate and reliable. The mechanism model function of structural water decomposition is confirmed by Satava method and Popescu method. The form of the most probable model function is G(α) = (1 – α)–1 – 1 (integral form) and f (α) = (1 – α)2 (differential form), and its mechanism is chemical reaction. This is verified by the criterion based on activation energy of model-free kinetics analysis.

As-cast Mg-6Li-0.3Zn-0.6Y and Mg-6Li-1.2Zn-1.2Y (wt%) alloys were prepared and extruded at 260 oC with an extrusion ratio of 25. The microstructure and mechanical behavior of as-cast and extruded alloys are reported and discussed. The results show that Mg-6Li-1.2Zn- 1.2Y alloy is composed of α-Mg, β-Li, and W-Mg3Zn3Y2 phases while Mg-6Li-0.3Zn-0.6Y alloy contains α-Mg, β-Li, W-Mg3Zn3Y2 phase and X-Mg12ZnY. After hot extrusion, the microstructure of specimens is refined and the average grains size of extruded alloys is 15 μm. Dynamic recrystallization occurs during the extrusion, leading to grain refinement of test alloys. Both the strength and elongation of test alloys are improved by extrusion. The extruded Mg-6Li-0.3Zn-0.6Y alloy possesses an ultimate strength of 225 MPa with an elongation of 18% while the strength and elongation of Mg-6Li-1.2Zn-1.2Y alloy are 206 MPa and 28%, respectively. The X-phase in Mg-6Li-0.3Zn- 0.6Y is beneficial to the improvement of strength, but will lead to the decrease of ductility.

In the current study, twenty lambs, aged 4 months, half male and half female, were classified into four groups, with five in each group. The experimental three groups of lambs were given intravenous (IV), intramuscular (IM) and subcutaneous (SC) administrations of recombinant ovine interferon-τ (roIFN-τ). The fourth group (normal control) of lambs was given normal saline injections in the same way. After administrations, blood samples were collected from the tested animals at different time points post injection, and the serum titers of roIFN-τ were measured using cytopathic effect (CPE) inhibition bioassay. The results of calculating pharmacokinetic (PK) parameters using DAS software showed that the PK characteristics of roIFN-τ through IV injection conformed to the two-compartment open model, whose half-life of distribution phases (T1/2α) was 0.33±0.034 h and the elimination half-life(T1/2β) was 5.01±0.24 h. However, the PK features of IM injection and SC injection of roIFN-τ conformed to the one compartment open model, whose Tmax were 3.11±0.26 h and 4.83±0.43 h, respectively, together with an elimination half life(T1/2β) of 9.11±0.76 h and 7. 43±0.58 h, and an absorption half-life (T1/2k(a)) of 1.13±0.31 h and 1.85±0.40 h, respectively. The bioavailability of roIFN-τ after IM administration reaches 73.57%, which is greater than that of SC administration (53.43%). These results indicate that the drug administration effect can be preferably obtained following a single dose IM administration of the roIFN-τ aqueous preparation. This study will facilitate the clinical application of roIFN-τ as a potential antiviral agent in future work.